IBDEI12W ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18330,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,18330,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,18331,0)
 ;;=B48.8^^79^878^62
 ;;^UTILITY(U,$J,358.3,18331,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18331,1,3,0)
 ;;=3^Mycoses NEC
 ;;^UTILITY(U,$J,358.3,18331,1,4,0)
 ;;=4^B48.8
 ;;^UTILITY(U,$J,358.3,18331,2)
 ;;=^5000689
 ;;^UTILITY(U,$J,358.3,18332,0)
 ;;=C49.9^^79^878^60
 ;;^UTILITY(U,$J,358.3,18332,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18332,1,3,0)
 ;;=3^Malig Neop of Connective/Soft Tissue,Unspec
 ;;^UTILITY(U,$J,358.3,18332,1,4,0)
 ;;=4^C49.9
 ;;^UTILITY(U,$J,358.3,18332,2)
 ;;=^5001136
 ;;^UTILITY(U,$J,358.3,18333,0)
 ;;=C85.80^^79^878^66
 ;;^UTILITY(U,$J,358.3,18333,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18333,1,3,0)
 ;;=3^Non-Hodgkin Lymphoma,Unspec Site NEC
 ;;^UTILITY(U,$J,358.3,18333,1,4,0)
 ;;=4^C85.80
 ;;^UTILITY(U,$J,358.3,18333,2)
 ;;=^5001721
 ;;^UTILITY(U,$J,358.3,18334,0)
 ;;=C85.89^^79^878^65
 ;;^UTILITY(U,$J,358.3,18334,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18334,1,3,0)
 ;;=3^Non-Hodgkin Lymphoma of Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,18334,1,4,0)
 ;;=4^C85.89
 ;;^UTILITY(U,$J,358.3,18334,2)
 ;;=^5001730
 ;;^UTILITY(U,$J,358.3,18335,0)
 ;;=E11.9^^79^878^22
 ;;^UTILITY(U,$J,358.3,18335,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18335,1,3,0)
 ;;=3^Diabetes Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,18335,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,18335,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,18336,0)
 ;;=E10.9^^79^878^21
 ;;^UTILITY(U,$J,358.3,18336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18336,1,3,0)
 ;;=3^Diabetes Type 1 w/o Complications
 ;;^UTILITY(U,$J,358.3,18336,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,18336,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,18337,0)
 ;;=D50.0^^79^878^57
 ;;^UTILITY(U,$J,358.3,18337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18337,1,3,0)
 ;;=3^Iron Deficiency Anemia Secondary to Blood Loss
 ;;^UTILITY(U,$J,358.3,18337,1,4,0)
 ;;=4^D50.0
 ;;^UTILITY(U,$J,358.3,18337,2)
 ;;=^267971
 ;;^UTILITY(U,$J,358.3,18338,0)
 ;;=D50.9^^79^878^58
 ;;^UTILITY(U,$J,358.3,18338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18338,1,3,0)
 ;;=3^Iron Deficiency Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,18338,1,4,0)
 ;;=4^D50.9
 ;;^UTILITY(U,$J,358.3,18338,2)
 ;;=^5002283
 ;;^UTILITY(U,$J,358.3,18339,0)
 ;;=D62.^^79^878^3
 ;;^UTILITY(U,$J,358.3,18339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18339,1,3,0)
 ;;=3^Acute Posthemorrhagic Anemia
 ;;^UTILITY(U,$J,358.3,18339,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,18339,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,18340,0)
 ;;=D64.9^^79^878^6
 ;;^UTILITY(U,$J,358.3,18340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18340,1,3,0)
 ;;=3^Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,18340,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,18340,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,18341,0)
 ;;=F03.90^^79^878^20
 ;;^UTILITY(U,$J,358.3,18341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18341,1,3,0)
 ;;=3^Dementia w/o Behavioral Disturbance,Unspec
 ;;^UTILITY(U,$J,358.3,18341,1,4,0)
 ;;=4^F03.90
 ;;^UTILITY(U,$J,358.3,18341,2)
 ;;=^5003050
 ;;^UTILITY(U,$J,358.3,18342,0)
 ;;=G30.9^^79^878^5
 ;;^UTILITY(U,$J,358.3,18342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18342,1,3,0)
 ;;=3^Alzheimer's Disease,Unspec
 ;;^UTILITY(U,$J,358.3,18342,1,4,0)
 ;;=4^G30.9
 ;;^UTILITY(U,$J,358.3,18342,2)
 ;;=^5003808
 ;;^UTILITY(U,$J,358.3,18343,0)
 ;;=G58.9^^79^878^61
 ;;^UTILITY(U,$J,358.3,18343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18343,1,3,0)
 ;;=3^Mononeuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,18343,1,4,0)
 ;;=4^G58.9
